Judith A. Shizuru

Judith A. Shizuru publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Judith A. Shizuru sits on this spectrum.

Judith A. Shizuru D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Judith A. Shizuru sits on this spectrum.

Best Publications

• Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

  Peter A. McSweeney;Peter A. McSweeney;Peter A. McSweeney;Dietger Niederwieser;Dietger Niederwieser;Dietger Niederwieser;Judith A. Shizuru;Judith A. Shizuru;Judith A. Shizuru;Brenda M. Sandmaier;Brenda M. Sandmaier;Brenda M. Sandmaier

  1660
  Citations

• Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases

  Dietger Niederwieser;Michael Maris;Judith A. Shizuru;Effie Petersdorf

  688
  Citations

• The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases.

  Irving L. Weissman;Judith A. Shizuru

  615
  Citations

• Tolerance and Chimerism after Renal and Hematopoietic-Cell Transplantation

  John D. Scandling;Stephan Busque;Sussan Dejbakhsh-Jones;Claudia Benike

  604
  Citations

• CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial

  Jay Y. Spiegel;Shabnum Patel;Lori Muffly;Nasheed M. Hossain

  531
  Citations

• Ablative Tumor Radiation Can Change the Tumor Immune Cell Microenvironment to Induce Durable Complete Remissions.

  Alexander Filatenkov;Jeanette Baker;Antonia M.S. Mueller;Justin Kenkel

  502
  Citations

• Loss of pancreatic islet tolerance induced by β-cell expression of interferon-γ

  N Sarvetnick;J Shizuru;D Liggitt;D Liggitt;L Martin

  497
  Citations

• Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes

  JA Shizuru;C Taylor-Edwards;BA Banks;AK Gregory

  496
  Citations

• Protective conditioning for acute graft-versus-host disease.

  Robert Lowsky;Tsuyoshi Takahashi;Yin Ping Liu;Sussan Dejbakhsh-Jones

  440
  Citations

• Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation.

  Heather G. Shilling;Karina L. McQueen;Nathalie W. Cheng;Judith A. Shizuru

  375
  Citations

• Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes.

  Jonathan T. Sockolosky;Eleonora Trotta;Giulia Parisi;Lora Picton

  364
  Citations

• Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.

  Mohamed L. Sorror;Barry E. Storer;Brenda M. Sandmaier;Michael Maris

  352
  Citations

• Treatment for Acute Myelogenous Leukemia by Low-Dose, Total-Body, Irradiation-Based Conditioning and Hematopoietic Cell Transplantation From Related and Unrelated Donors

  Ute Hegenbart;Dietger Niederwieser;Brenda M. Sandmaier;Michael B. Maris

  331
  Citations

• Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation.

  Maria T Millan;Judith A Shizuru;Petra Hoffmann;Sussan Dejbakhsh-Jones

  303
  Citations

• Expansion of cytolytic CD8+ natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon γ production

  Jeanette Baker;Michael R. Verneris;Maki Ito;Judith A. Shizuru

  295
  Citations

• Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma

  Steven M. Horwitz;Robert S. Negrin;Karl G. Blume;Sheila Breslin

  260
  Citations

• Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Myeloid Leukemia

  Boglarka Gyurkocza;Rainer Storb;Barry E. Storer;Thomas R. Chauncey

  252
  Citations

• Chimerism, Graft Survival, and Withdrawal of Immunosuppressive Drugs in HLA Matched and Mismatched Patients After Living Donor Kidney and Hematopoietic Cell Transplantation

  J. D. Scandling;S. Busque;J. A. Shizuru;R. Lowsky

  245
  Citations

• Islet allograft survival after a single course of treatment of recipient with antibody to L3T4.

  JA Shizuru;AK Gregory;CT Chao;CG Fathman

  240
  Citations

• TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors.

  Holbrook E. Kohrt;Brit B. Turnbull;Kartoosh Heydari;Judith A. Shizuru

  237
  Citations